Company profilePharmaceutical#231 of 1,318 in Pakistan3 DRAP alerts

ARIES PHARMACEUTICALS (PVT) LTD

Pharmaceutical company · 79 brands · 67 molecules

Ranked #11 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

79 registered products 35 pharmaceutical brands 67 distinct molecules 3 DRAP alerts

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

ARIES PHARMACEUTICALS (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 79 product registrations across 67 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Quinolone Antibacterials. DRAP has issued 3 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by ARIES

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Gastro 1

Esox40mgRs 320

Top molecules by brand count

Paracetamol5 brands

Diclofenac4 brands

Ciprofloxacin3 brands

Orphenadrine3 brands

Rabeprazole3 brands

Piroxicam3 brands

Iron Polymaltose Complex3 brands

Pantoprazole3 brands

Esomeprazole2 brands

Loratadine2 brands

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

Servaid1 products · Rs 320 – Rs 320

Median across source: Rs 320

Regulatory record

3 alerts in the DRAP feed we track.

Recall Alert: Recall of Substandard Flagynase Suspension (Reg. No. 087528) Batch No. 0362

2024-11-21

Recall Alert: Drug Product; Oscal-D Tablets (Batch # 6904) by M/s Aries Pharmaceuticals (P

2023-03-01

Drug Product Recall; Flagynase Suspension (Batch # 0244) by M/s. Aries Pharmaceuticals Pvt

2022-04-08

Competitive set

Companies whose registered portfolio overlaps most with this one.

Wilshire Laboratories (Private) Limited35 shared molecules

DANAS PHARMACEUTICALS (PVT) LTD31 shared molecules

GENOME PHARMACEUTICALS (PVT) LTD30 shared molecules

Paramount Pharmaceuticals (Pvt) Ltd.30 shared molecules

BIO LABS (PVT) LTD.29 shared molecules

SHROOQ PHARMACEUTICALS28 shared molecules

MEDICRAFT PHARMACEUTICALS (PVT) LTD.27 shared molecules

MEDIATE PHARMACEUTICALS (PVT) LTD27 shared molecules

MEDISURE LABORATORIES PAKISTAN (PVT.) LTD.27 shared molecules

Pulse Pharmaceuticals (Pvt.) Ltd.27 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 132 molecules not in this portfolio

DANAS PHARMACEUTICALS (PVT) LTD holds 42 molecules not in this portfolio

GENOME PHARMACEUTICALS (PVT) LTD holds 113 molecules not in this portfolio

Get the full profile for ARIES

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included